<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01099501</url>
  </required_header>
  <id_info>
    <org_study_id>PHMD- OT- 01</org_study_id>
    <nct_id>NCT01099501</nct_id>
  </id_info>
  <brief_title>Oxepa in Multiple Trauma</brief_title>
  <acronym>OMT</acronym>
  <official_title>Oxepa in Multiple Trauma: Prospective, Randomized, Comparative, Double-blind, Controlled Clinical Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rabin Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Israeli Ministry of Security</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Rabin Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a single-center, prospective, randomized, comparative, double-blind controlled
      clinical study mend to assess the effect of enteral feeding with Oxepa (a fish oil-based
      nutrition), compared to an isocaloric control, on oxygenation and clinical outcomes in
      mechanically ventilated trauma patients.

      The study population will be adults admitted to the ICU due to multiple-trauma or head trauma
      as a result of a gun shut, motor vehicle accidents, fall, workplace accident etc.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary outcome:

      Improvement in oxygenation

      Secondary outcomes:

      Significant improvement in other clinical and laboratory end points.

      Primary endpoint:

      Pulmonary function:

      Oxygenation (PO2- FIO2 ratio)

        -  Incidence of ALI

        -  Length of Ventilation (LOV)

      Secondary endpoints:

      Rate of complications:

      -New organ failure.

      Rate of new infections:

      -wound infection, bacteremia, ventilation associated pneumonia.

      Pain:

      -Pain score and analgesic use

      Morbidity/ mortality:

        -  Length of ICU stay

        -  Length of hospitalization

        -  28 day mortality

        -  Hospital mortality

      All patients will commence enteral feeding via a nasogastric or orogastric tube; allocation
      to either Oxepa or Pulmocare/Jevity (control group) will be determined by randomization code.
      Patients will be prescribed to receive a daily amount of enteral formula that provides at
      least 80% of their energy; the latter will be calculated every 48 to 72 hours by Indirect
      Calorimetric (IC) measurement of Resting Energy Expenditure (REE). Tolerance of EN will be
      assessed by measurement of Gastric Residual Volume (GRV) every 8 hrs and the mode of feeding
      will be modified accordingly.

      Treatment:

      Enrolled patients will be randomly divided into a control group and an intervention group.

      Control group treatment:

      Will be administered Pulmocare or Jevity (enteral nutrition formula, ABBOTT), at a dose
      determined by a patient's energy expenditure and tolerance of enteral feeding.

      Intervention group treatment:

      Will be administered with Oxepa (enteral nutrition formula, ABBOTT), at a dose determined by
      a patient's energy expenditure and tolerance of enteral feeding.

      Treatment duration:

      The above formulas will be/delivered until the first of the following occurs:

        -  patients resume regular oral feeding

        -  day 28/ discharge from ICU/ exitus

        -  Patients transferred to Total Parenteral Nutrition Note: the attending physician
           according to the patient's needs will determine feeding of patients from there on.

      Study termination (end of all study procedures):

        -  day 28/ discharge from ICU

        -  Patients transferred to Total Parenteral Nutrition before day 3 of the study
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2010</start_date>
  <completion_date type="Anticipated">August 2014</completion_date>
  <primary_completion_date type="Anticipated">May 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Oxygenation (PO2/FIO2 ratio)</measure>
    <time_frame>2 years</time_frame>
    <description>PO2/FIO2 ratio; assessed by measuring arterial blood gases (AVL Omni Technology, Graz, Austria) and ventilator settings (10)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>TNF-α, CRP (markers of inflammatory response)</measure>
    <time_frame>2 years</time_frame>
    <description>Concentration of circulating inflammatory markers: TNF-α, CRP concentrations</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fatty acid composition of RBC phospholipids, including n-3:n-6 ratio (markers of n-3 PUFA incorporation into blood cell membranes)</measure>
    <time_frame>2 years</time_frame>
    <description>Fatty acid composition of RBC membrane (thin liquid chromatography)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Multiple Trauma</condition>
  <condition>Head Trauma</condition>
  <arm_group>
    <arm_group_label>Oxepa</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Oxepa (enteral nutrition formula, ABBOTT)will be administered at a dose determined by a patient's energy expenditure and tolerance of enteral feeding.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Pulmocare or Jevity (enteral nutrition formula, ABBOTT)will be administered at a dose determined by a patient's energy expenditure and tolerance of enteral feeding.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Oxepa (enteral nutrition formula, ABBOTT), at a dose determined by a patient's energy expenditure and tolerance of enteral feeding.</intervention_name>
    <description>Oxepa will be administered(enteral nutrition formula, ABBOTT), at a dose determined by a patient's energy expenditure and tolerance of enteral feeding</description>
    <arm_group_label>Oxepa</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>oxepa</intervention_name>
    <description>A dose determined by a patient's energy expenditure and tolerance of enteral feeding.</description>
    <arm_group_label>Oxepa</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Control group</intervention_name>
    <description>Pulmocare or Jevity (enteral nutrition formula, ABBOTT)will be administered at a dose determined by a patient's energy expenditure and tolerance of enteral feeding.</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Males and females aged 18-90 years with multiple-trauma or head trauma admitted to the
             ICU.

          2. Enteral nutrition can be initiated within 36 hours of admission/ injury.

          3. Mechanical ventilation.

        Exclusion criteria:

          1. Severe underlying systemic disease and /or treatment with immunosuppressive agents.

          2. Contra-indication for Enteral Nutrition (mechanical or functional bowel. obstruction,
             high-output fistula, severe necrotizing pancreatitis).

          3. 2nd /3rd degree burns covering &gt; 66% BSA.

          4. Pregnancy.

          5. Participants under the age of 18.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pierre Singer, MD, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rabin Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pierre Singer, Principal Investigator MD</last_name>
    <phone>972-3-9376521</phone>
    <email>psinger@clalit.org.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Rabin Medical Center, Campus Beilinson</name>
      <address>
        <city>Petach Tikva</city>
        <zip>49100</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre Singer, MD</last_name>
      <phone>972-39376521</phone>
      <email>psinger@clalit.org.il</email>
    </contact>
    <contact_backup>
      <last_name>Milana Grinev, Study Coordinator</last_name>
      <phone>972-39376521</phone>
      <email>milang@clalit.org.il</email>
    </contact_backup>
    <investigator>
      <last_name>Shaul Lev, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ilya Kagan, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Miriam Ben Harosh Katz, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Milana Grinev, RN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Miriam Theilla, RN, MSC</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Shapiro Haim, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ronit Anbar, RD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dana Pinsker, RD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <reference>
    <citation>MacCallum NS, Evans TW. Epidemiology of acute lung injury. Curr Opin Crit Care. 2005 Feb;11(1):43-9. Review.</citation>
    <PMID>15659944</PMID>
  </reference>
  <reference>
    <citation>Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994 Mar;149(3 Pt 1):818-24. Review.</citation>
    <PMID>7509706</PMID>
  </reference>
  <reference>
    <citation>Moore FA, Moore EE, Jones TN, McCroskey BL, Peterson VM. TEN versus TPN following major abdominal trauma--reduced septic morbidity. J Trauma. 1989 Jul;29(7):916-22; discussion 922-3.</citation>
    <PMID>2501509</PMID>
  </reference>
  <reference>
    <citation>Kudsk KA, Croce MA, Fabian TC, Minard G, Tolley EA, Poret HA, Kuhl MR, Brown RO. Enteral versus parenteral feeding. Effects on septic morbidity after blunt and penetrating abdominal trauma. Ann Surg. 1992 May;215(5):503-11; discussion 511-3.</citation>
    <PMID>1616387</PMID>
  </reference>
  <reference>
    <citation>Kudsk KA, Minard G, Croce MA, Brown RO, Lowrey TS, Pritchard FE, Dickerson RN, Fabian TC. A randomized trial of isonitrogenous enteral diets after severe trauma. An immune-enhancing diet reduces septic complications. Ann Surg. 1996 Oct;224(4):531-40; discussion 540-3.</citation>
    <PMID>8857857</PMID>
  </reference>
  <reference>
    <citation>Moore FA, Moore EE, Kudsk KA, Brown RO, Bower RH, Koruda MJ, Baker CC, Barbul A. Clinical benefits of an immune-enhancing diet for early postinjury enteral feeding. J Trauma. 1994 Oct;37(4):607-15.</citation>
    <PMID>7932892</PMID>
  </reference>
  <reference>
    <citation>Todd SR, Gonzalez EA, Turner K, Kozar RA. Update on postinjury nutrition. Curr Opin Crit Care. 2008 Dec;14(6):690-5. doi: 10.1097/MCC.0b013e3283196562. Review.</citation>
    <PMID>19005311</PMID>
  </reference>
  <reference>
    <citation>Singer P, Theilla M, Fisher H, Gibstein L, Grozovski E, Cohen J. Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma-linolenic acid in ventilated patients with acute lung injury. Crit Care Med. 2006 Apr;34(4):1033-8. Erratum in: Crit Care Med. 2006 Jun;34(6):1861.</citation>
    <PMID>16484911</PMID>
  </reference>
  <reference>
    <citation>Green P, Hermesh H, Monselise A, Marom S, Presburger G, Weizman A. Red cell membrane omega-3 fatty acids are decreased in nondepressed patients with social anxiety disorder. Eur Neuropsychopharmacol. 2006 Feb;16(2):107-13. Epub 2005 Oct 21.</citation>
    <PMID>16243493</PMID>
  </reference>
  <results_reference>
    <citation>Giannoudis PV. Current concepts of the inflammatory response after major trauma: an update. Injury. 2003 Jun;34(6):397-404. Review.</citation>
    <PMID>12767787</PMID>
  </results_reference>
  <results_reference>
    <citation>Leaver SK, Evans TW. Acute respiratory distress syndrome. BMJ. 2007 Aug 25;335(7616):389-94. Review.</citation>
    <PMID>17717368</PMID>
  </results_reference>
  <results_reference>
    <citation>Singer P, Cohen J: Indirect calorimetry and metabolic monitoring. In Fink M, Abraham E (eds), Textbook of Critical Care, Springer eds (Berlin), 2005 pp.]</citation>
  </results_reference>
  <results_reference>
    <citation>Gaynes RP, Horan TC. Surveillance of Nosocomial Infections.In: Mayhall CG, editor. Hospital Epidemiology and Infection Control. Philadelphia: Lippincott Williams &amp; Wilkins,1285-1317,1999</citation>
  </results_reference>
  <verification_date>October 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 1, 2010</study_first_submitted>
  <study_first_submitted_qc>April 6, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 7, 2010</study_first_posted>
  <last_update_submitted>November 21, 2013</last_update_submitted>
  <last_update_submitted_qc>November 21, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 25, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rabin Medical Center</investigator_affiliation>
    <investigator_full_name>Pierre singer</investigator_full_name>
    <investigator_title>Professor, MD</investigator_title>
  </responsible_party>
  <keyword>Mechanical Ventilation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Craniocerebral Trauma</mesh_term>
    <mesh_term>Multiple Trauma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

